EUROPE – The General Court Limits the Scope of “Satisfactory Methods” That Must Be Compared for Orphan Drug Designation

Published date06 October 2020
Subject MatterEuropean Commission,EU,World Health Organization,Orphan Drugs,Pharmaceutical Industry,General Court of the European Union (GCEU),European Medicines Agency (EMA)
AuthorChristina Markus,Geneviève Michaux,Cassandra Rasmussen
Law FirmKing & Spalding

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT